Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Current Leases (2021 - 2025)

Historic Current Leases for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to $2.7 million.

  • Kiniksa Pharmaceuticals International's Current Leases rose 3274.25% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 3274.25%. This contributed to the annual value of $2.0 million for FY2024, which is 1154.02% down from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Current Leases stood at $2.7 million, which was up 3274.25% from $2.5 million recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's Current Leases' 5-year high stood at $3.5 million during Q1 2023, with a 5-year trough of $2.0 million in Q4 2024.
  • In the last 5 years, Kiniksa Pharmaceuticals International's Current Leases had a median value of $2.5 million in 2025 and averaged $2.7 million.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 3946.93% in 2022, then plummeted by 3454.91% in 2024.
  • Kiniksa Pharmaceuticals International's Current Leases (Quarter) stood at $3.4 million in 2021, then fell by 2.37% to $3.3 million in 2022, then crashed by 31.75% to $2.3 million in 2023, then fell by 11.54% to $2.0 million in 2024, then skyrocketed by 35.27% to $2.7 million in 2025.
  • Its Current Leases stands at $2.7 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.3 million for Q1 2025.